These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15066411)

  • 1. The multiple actions of black widow spider toxins and their selective use in neurosecretion studies.
    Ushkaryov YA; Volynski KE; Ashton AC
    Toxicon; 2004 Apr; 43(5):527-42. PubMed ID: 15066411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insecticidal toxins from black widow spider venom.
    Rohou A; Nield J; Ushkaryov YA
    Toxicon; 2007 Mar; 49(4):531-49. PubMed ID: 17210168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular architecture of black widow spider neurotoxins.
    Chen M; Blum D; Engelhard L; Raunser S; Wagner R; Gatsogiannis C
    Nat Commun; 2021 Nov; 12(1):6956. PubMed ID: 34845192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Black widow spider alpha-latrotoxin: a presynaptic neurotoxin that shares structural homology with the glucagon-like peptide-1 family of insulin secretagogic hormones.
    Holz GG; Habener JF
    Comp Biochem Physiol B Biochem Mol Biol; 1998 Oct; 121(2):177-84. PubMed ID: 9972293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The black widow's versatile venom.
    Saibil HR
    Nat Struct Biol; 2000 Jan; 7(1):3-4. PubMed ID: 10625413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Brown and Southern Black Widow Spider (Araneae: Theridiidae) Latrotoxins Is Tissue- and Life Stage-Specific for α-Latroinsectotoxins and δ-Latroinsectotoxins and Is Ubiquitous for α-Latrotoxins.
    Torres SL; Landeros A; Penhallegon EJ; Salazar K; Porter LM
    J Med Entomol; 2022 Jan; 59(1):184-191. PubMed ID: 34632517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. House spider genome uncovers evolutionary shifts in the diversity and expression of black widow venom proteins associated with extreme toxicity.
    Gendreau KL; Haney RA; Schwager EE; Wierschin T; Stanke M; Richards S; Garb JE
    BMC Genomics; 2017 Feb; 18(1):178. PubMed ID: 28209133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Black widow spider toxins: the present and the future.
    Grishin EV
    Toxicon; 1998 Nov; 36(11):1693-701. PubMed ID: 9792186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dramatic expansion of the black widow toxin arsenal uncovered by multi-tissue transcriptomics and venom proteomics.
    Haney RA; Ayoub NA; Clarke TH; Hayashi CY; Garb JE
    BMC Genomics; 2014 Jun; 15(1):366. PubMed ID: 24916504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular evolution of α-latrotoxin, the exceptionally potent vertebrate neurotoxin in black widow spider venom.
    Garb JE; Hayashi CY
    Mol Biol Evol; 2013 May; 30(5):999-1014. PubMed ID: 23339183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene structure, regulatory control, and evolution of black widow venom latrotoxins.
    Bhere KV; Haney RA; Ayoub NA; Garb JE
    FEBS Lett; 2014 Nov; 588(21):3891-7. PubMed ID: 25217831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha Latrotoxin of black widow spider venom binds to a specific receptor coupled to phosphoinositide breakdown in PC12 cells.
    Vicentini LM; Meldolesi J
    Biochem Biophys Res Commun; 1984 Jun; 121(2):538-44. PubMed ID: 6145415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-Latrotoxin and its receptors.
    Ushkaryov YA; Rohou A; Sugita S
    Handb Exp Pharmacol; 2008; (184):171-206. PubMed ID: 18064415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Research on Widow Spider Venoms and Toxins.
    Yan S; Wang X
    Toxins (Basel); 2015 Nov; 7(12):5055-67. PubMed ID: 26633495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latrophilin, neurexin, and their signaling-deficient mutants facilitate alpha -latrotoxin insertion into membranes but are not involved in pore formation.
    Volynski KE; Meunier FA; Lelianova VG; Dudina EE; Volkova TM; Rahman MA; Manser C; Grishin EV; Dolly JO; Ashley RH; Ushkaryov YA
    J Biol Chem; 2000 Dec; 275(52):41175-83. PubMed ID: 11024019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High affinity binding of alpha-latrotoxin to recombinant neurexin I alpha.
    Davletov BA; Krasnoperov V; Hata Y; Petrenko AG; Südhof TC
    J Biol Chem; 1995 Oct; 270(41):23903-5. PubMed ID: 7592578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant alpha-latrotoxin (LTXN4C) does not form pores and causes secretion by receptor stimulation: this action does not require neurexins.
    Volynski KE; Capogna M; Ashton AC; Thomson D; Orlova EV; Manser CF; Ribchester RR; Ushkaryov YA
    J Biol Chem; 2003 Aug; 278(33):31058-66. PubMed ID: 12782639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin B1 thiazole derivative reduces transmembrane current through ionic channels formed by toxins from black widow spider venom and sea anemone in planar phospholipid membranes.
    Shatursky OY; Volkova TM; Romanenko OV; Himmelreich NH; Grishin EV
    Biochim Biophys Acta; 2007 Feb; 1768(2):207-17. PubMed ID: 17150177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of alpha-latrotoxin action.
    Henkel AW; Sankaranarayanan S
    Cell Tissue Res; 1999 May; 296(2):229-33. PubMed ID: 10382267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of alpha-latrotoxin oligomers reveals that divalent cation-dependent tetramers form membrane pores.
    Orlova EV; Rahman MA; Gowen B; Volynski KE; Ashton AC; Manser C; van Heel M; Ushkaryov YA
    Nat Struct Biol; 2000 Jan; 7(1):48-53. PubMed ID: 10625427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.